259
Views
15
CrossRef citations to date
0
Altmetric
Research Articles

Pharmacology mechanism of Flos magnoliae and Centipeda minima for treating allergic rhinitis based on pharmacology network

, , , , , , , , , , & show all
Pages 1547-1555 | Received 28 Mar 2019, Accepted 19 Jun 2019, Published online: 05 Jul 2019

References

  • Hoyte FCL, Nelson HS. Recent advances in allergic rhinitis. F1000Res. 2018;7:3
  • Meng XX, Sun SM, Song LC. Professor Song Lucheng's experience in treating allergic rhinitis. World Latest Med Inform. 2018;18:222.
  • Cvetkovski B, Tan R, Kritikos V, et al. A patient-centric analysis to identify key influences in allergic rhinitis management. NPJ Prim Care Respir Med. 2018;28:34.
  • Lin C, Zhu WN, Wang JY. Effects of tqbyao rhinitis granule combined with hormone spray on serum inflammatory factors and nasal physiological functions in patients with allergic rhinitis. Chin Arch Trad Chin Med. 2018;36:959.
  • Peng W, Wang W, Li ZW. Effects of montelukast sodium combined with fluticasone propionate on symptoms and quality of life in patients with allergic rhinitis. Eval Anal Drug-Use Hosp China. 2018;18:636–638.
  • Yang JS. Experimental and network pharmacology study of Tongbizhiqiufang inhibition of allergic rhinitis [dissertation]. Hubei university of Chinese medicine. 2016.
  • Jung YS, Weon JB, Yang WS, et al. Neuroprotective effects of Magnoliae Flos extract in mouse hippocampal neuronal cells. Sci Rep. 2018;8:9693.
  • Zhang TT, Guo XL, Huang XY, et al. GC–MS analysis of volatile oil of Flos magnoliae and its antioxidant and antibacterial activity. Food Sci. 2016;37:144–150.
  • Li XL, Zhang YZ. Experimental study on the anti-allergy of volatile oil of Flos magnoliae. Chin J Hosp Pharm. 2002;9:8–9.
  • Yu HM, Wen SL, Liu ZG, et al. An experimental study on the treatment of allergic rhinitis in Centipeda minima. Chin J Otorhinolaryngol Integr Med. 2001;5:220–224.
  • Guo YQ, Sun HY, Chan CO, et al. Centipeda minima (Ebushicao) extract inhibits PI3K-Akt-mTOR signaling in nasopharyngeal carcinoma CNE-1 cells. Chin Med. 2015;10:26.
  • Lin YC, Gao M. Advances in chemical composition and pharmacology of Centipeda minima. J Zhejiang Chin Med Univ. 2011;35:303–304.
  • Huang Zhang YL, Liu X, Huo M, et al. The anti-inflammatory and analgesic activity of the Centipeda minima volatile oil. Chin J Spectrosc Lab. 2013;30:1913–1921.
  • Xiong YA, Wen ML, Lv JJ, et al. A study on the therapeutic effect of nasal ning spray for allergic rhinitis. Modern Trad Chin Med Mater Med-World Sci Technol. 2017;19:880–884.
  • Zhang SN, Zhang YY. Advances in clinical application and pharmacology of Centipeda minima. Agric Jilin. 2015;19:76–77.
  • Jin S, Song M. Effect of xinyi biyan pill combined with budesonide on allergic rhinitis and its effect on relevant inflammatory factors. China Pharm. 2017;28:2483–2485.
  • Zhang JK. Clinical study on treatment of allergic rhinitis of lung transcorbution by Xinyi Qingluntongyang decoction. Shandong University of Traditional Chinese Medicine; 2015.
  • Bian HX. Clinical study on treatment of 30 cases of allergic rhinitis by Centipeda minima mixture [dissertation]. Changchun University of Chinese Medicine; 2014.
  • Lv PF. Clinical observation on the treatment of seasonal allergic rhinitis with Xin yi Qingfei granule [dissertation]. Heilongjiang University of Chinese Medicine; 2017.
  • Zhi DM, Sui DJ, Qi R, et al. To explore the potential target of pueraria for the treatment of hyperlipoproteinemia based on network pharmacology. J Jilin Univ (Med Ed). 2018;44:724–730, +891.
  • Fan WT, Wang Q. Mechanism of Acori Tatarinowii Rhizoma-Curcumae Radix treating depression based on network pharmacology. China J Chin Mater Med. 2018;43:2607–2611.
  • Sun YH, Lu JK, Wang J, et al. The mechanism of sanwei sandalwood powder for treating coronary heart disease based on network pharmacology. Chin J New Drugs Clin Remed. 2018;37:272–289.
  • Liu C, Yuan Y, Zhao WT, et al. The target and mechanism of hypericin in the treatment of atherosclerosis were predicted by network pharmacology. Mod Chin Med. 2018;20:684–690 + 701.
  • Onishi T, Honda A, Tanaka M, et al. Ambient fine and coarse particles in Japan affect nasal and bronchial epithelial cells differently and elicit varying immune response. Environ Pollut. 2018;242:1693–1701.
  • Lenon GB, Xue CC, Story DF, et al. Inhibition of release of inflammatory mediators in primary and cultured cells by a Chinese herbal medicine formula for allergic rhinitis. Chin Med. 2007;2:2.
  • Sayin I, Cingi C, Oghan F, et al. Complementary therapies in allergic rhinitis. ISRN Allergy. 2013;2013:1–9.
  • Guan Z, Ma XZ, Lv GY, et al. Effects of volatile oil of Flos magnoliae on IL-12, IFN-γ and histamine in rats with allergic rhinitis. Pharmacol Clin Chin Mater Med. 2011;27:70–72.
  • Huang Y, Yang XL, Ni YH, et al. Geraniol suppresses proinflammatory mediators in phorbol 12-myristate 13-acetate with A23187-induced HMC-1 cells. Drug Des Devel Ther. 2018;12:2897–2903.
  • Wang H, Zhao ZY, Shen X, et al. To study the mechanism of polygala in the treatment of Alzheimer's disease based on systematic pharmacology. Acta Pharm Sin. 2017; 52:1554–1561.
  • Liu X. Based on network pharmacology, the mechanism of treating asthma by Yupingfeng powder was studied [dissertation]. Southwest Jiaotong University; 2017.
  • Liu Y, Zhang FB, Tang SH, et al. Analysis on “component–target–pathway” of Paeonia lactiflora in treating cardiac diseases based on data mining. Zhongguo Zhong Yao Za Zhi. 2018; 43:1310–1316.
  • Zhi LQ, Yang YX, Yao SX, et al. Identification of novel target for osteosarcoma by network analysis. Med Sci Monit. 2018;24:5914–5924.
  • Niu XW, Zhang JJ, Ni JR, et al. Network pharmacology-based identification of major component of Angelica sinensis and its action mechanism for the treatment of acute myocardial infarction. Biosci Rep. 2018;38:4–6.
  • Chen FS, Jiang HY, Jiang Z. Prediction of drug-pathway interaction pairs with a disease-combined LSA-PU-KNN method. Mol Biosyst. 2017;13:2583–2591.
  • Gilles S, Akdis C, Lauener R, et al. The role of environmental factors in allergy: a critical reappraisal. Exp Dermatol. 2018;27:1193.
  • Tonnel A, Capron M. Recent data on the physiopathology of respiratory allergies. Bull Acad Natl Med. 1997;181:1563–1574.
  • Ren K, Li T. Current status and progress of immunological detection of allergic rhinitis. China Contin Med Educ. 2017;9:53–54.
  • Liu GL, Li CY, Chen M. The curative effect of tbi prescription combined with acupuncture on allergic rhinitis and its effect on serum IL-4, IL-6 and IL-10. Mod J Integr Trad Chin West Med. 2018;27:2347–2350.
  • Yu ZZ, Fu YQ, Li GY. Expression levels of serum IL_6_IL_17 and TNF_ in patients with allergic rhinitis and their significance. J Prev Med Chin People's Liber Army. 2017;35:369–370 + 373.
  • Zhao YL, Zhang Y, Wang CS, et al. Study on the correlation between the non-synonymous rs2228145 of interleukin-6 receptor gene and Chinese patients with allergic rhinitis. J Capital Med Univ. 2017;38:695–699.
  • Kim HY, Jeong HJ, Kim HM. Anti-allergic and anti-inflammatory effects of the Bcl-2 inhibitor ABT-737 on experimental allergic rhinitis models. Eur J Pharmacol. 2018;833:34–43.
  • Xue JM, Yang LT, Yang G, et al. Protease-activated receptor-2 suppresses interleukin (IL)-10 expression in B cells via upregulating Bcl2L12 in patients with allergic rhinitis. Allergy. 2017;72:1704–1712.
  • Yu W, Mao L, Pan Q, et al. Efficacy of sublingual administration of dermatophagoides farinae drops for treatment of pediatric allergic rhinitis accompanied by adenoid hypertrophy and improvement of immune function. Med Sci Monit. 2019;25:333–340.
  • Xu J, Han X, Nancy E, et al. Nasal mucosal effect of muscarinic acetylcholine receptor. Prog Physiol Sci. 2009;40:261–263.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.